-
Plenary session explores the potent, dynamic terrain of artificial intelligence applications in oncology
Researchers explored the potential of artificial intelligence for accelerating evidence generation, advancing disparities research, and improving trial design during a plenary session on the final day of the AACR Annual Meeting 2024.
-
Study findings highlight potential of novel immunotherapy strategies
Sundar Jagannath, MD, and other presenters discussed emerging results on immunotherapy approaches beyond immune checkpoint inhibitors during a clinical trials plenary session.
-
Clinical trials evaluate novel immune checkpoint inhibitor combinations
Deborah J. Wong, MD, PhD, and other speakers presented findings on novel combinations of immune checkpoint inhibitors during a clinical trials plenary session.
More News from #AACR24
-
Seminal research on the underpinnings of metastasis presented in plenary session
Sarah-Maria Fendt, PhD, and other researchers tackled the evolution of the genome, microenvironment, and host through metastasis during a plenary session.
-
Presidential Address charts the long, winding road to engineering T cells
AACR Immediate Past President Philip D. Greenberg, MD, FAACR, explored his own continuing experience with engineering T cells to eradicate tumors during a lecture at the Annual Meeting.
-
Pezcoller Foundation-AACR award recipient details work on telomeres
Titia de Lange, PhD, FAACR, was recognized with the Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research and presented a lecture on telomeres and cancer, including tumor suppression and genome instability.
-
NCI Director lays out new framework for tackling cancer at multiple levels
National Cancer Institute Director W. Kimryn Rathmell, MD, PhD, spoke Monday at the Annual Meeting about the importance of innovative and engaging collaborations in the fight to end cancer as we know it.
-
Highlights for Wednesday, April 10: Plenary sessions on artificial intelligence, Annual Meeting takeaways
Annual Meeting Program Chairs Keith T. Flaherty, MD, FAACR, and Christina Curtis, PhD, MSc, preview Wednesday’s program to help you plan your schedule for the final day at the Annual Meeting 2024.
-
Panelists to explore new and emerging advances in precision chemoprevention
Adetunji Toriola, MD, PhD, will chair a Wednesday morning session on the potential impact chemoprevention can have on reducing cancer burden.